Skip to main content
. 2021 Apr 9;97(4):161–196. doi: 10.2183/pjab.97.010

Table 3.

Plasma phosphatidylcholine hydroperoxide (PCOOH) in hyperlipidemia

Subjects n PCOOH (nmol/L)a P
vs controls vs normalized
Controls 47 160 ± 65    
Hyperlipidemia        
 Normalized 13 202 ± 17 NSb  
 Type IIa 34 322 ± 32 <0.05 <0.01
 Type IIb 24 353 ± 28 <0.01 <0.01
 Type IV 23 397 ± 48 <0.01 <0.001

aMean ± SE.

bNS, not significant.

Adapted with permission from Ref. 70. Copyright 2000 Oxford University Press.